Researchers find an upsurge in antimicrobial-resistant C. auris infections

FHS
June 18, 2023
3:56 pm

Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten U.S. public health.

177Lu-PNT6555 by POINT Biopharma Global for Metastatic Melanoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 26, 2023

Advamed asks CMS to cover extra imaging of dense breast tissue

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Advamed has asked for Medicare to cover

November 6, 2024

Quabodepistat combo shows promise for safer, faster tuberculosis treatment

Study highlights the safety and early bactericidal activity of quabodepistat when combined with delamanid, bedaquiline, or both, offering potential for shorter and more tolerable tuberculosis

December 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.